Abstract
The myelodysplastic syndromes (MDS) comprise a heterogeneous group of hematological disorders characterized by ineffective hematopoiesis with a high frequency of progression into acute myeloid leukemia (AML; [Heaney and Golde, 1999]). During the last few years, compelling evidence has accumulated indicating the clonal nature of MDS ([Kere et al., 1987]; [Janssen et al., 1989]). The identity of the cell in which transformation takes place, however, is still not clear. Some studies suggest that the transformation event in MDS occurs at the level of a committed myeloid progenitor ([Kroef et al., 1993]; [Saitoh et al., 1998]); this is supported by the fact that MDS rarely transforms into acute lymphoblastic leukemia. In contrast, a recent study by [Nilsson et al (2000)] shows evidence that transformation may occur on a lympho-myeloid stem cell, suggesting that the apparent myeloid-lineage restriction is a result of the transforming event itself. Regardless of these two possible scenarios the fact is that severe hematopoietic alterations exist in MDS, both at the level of hematopoietic progenitors and their marrow microenvironment ([Yoshida, 1987]; [Mayani, 1993]).
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams JA, Liu Yin JA, Brereton ML, Briggs M, Burgess R & Hyde K (1997) The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on mcgakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukemia.British Journal of Haematology99, 139–146
Aizawa S, Nakano M, Iwase O, Yaguchi M, Hiramoto M, Hoshi H, Nabeshima R, Shima D, Handa H&Toyama K (1999) Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro.Leukemia Research23, 239–246
Aizawa S, Hiramoto M, Hoshi H, Toyama K, Shima D & Handa H (2000) Establishment of stromal cell line from an MDS RA patient which induced an apoptotic change in hematopoietic and leukemic cell in vitro.Experimental Hematology28, 148–155
Asano H, Hotta T, Ichihara M, Murate T, Kobayashi M & Saito H (1994) Growth analysis of marrow CD34-positive hematopoietic progneitor cells in patients with myelodysplastic syndromes.Leukemia8, 833–838
Backx B, Broeders L, Hoefsloot LH, Wognum B & Lowenberg B (1996) Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.Leukemia 10466–472
Baines P, Bowen D & Jacobs A (1990) Clonal growth of haemopoietic progenitor cells from myelodysplastic marrow in response to recombinant haemopoietins.Leukemia Research14, 247–253
Bhatia M, Bonnet D, Murdoch B, Gan 01 & Dick JE (1998) A newly discovered class of human hematopoietic cells with SCID repopulating activity.Nature Medicine4, 1038–1045
Borbenyi Z, Cinkotai C, Harrison C & Testa NG (1987) The growth of myelodysplastic bone marrow in long-term cultures.British Journal of Cancer55, 291–293
Carlo-Stella C, Cazzola M, Bergamaschi C, Bemasconi P, Dezza L, Invemizzi R & Pedrazzoli P (1989) Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony stimulating factor.Leukemia3, 363–366
Civin CI & Gore SD (1993) Antigenic analysis of hematopoiesis: a review. Journal of Hematotherapy 2, 137–144
Conneally E, Cashman J, Petzer A & Eaves CJ (1997) Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic seid/seid mice.Proceeding of the National Academy of Sciences USA94, 9836–9841
Coutinho LH, Geary CG, Chang J, Harrison C & Testa NG (1990) Functional studies of bone marrow haemopoietic and stromal cells in thcmyelodysplastic syndrome (MDS).British Journal of Haematology75, 16–25
Dan K, An E, Futaki M, Inokuchi K, Gomi S, Yamada T, Ogata K, Tanabe Y, Ohki 1, Shinohara T & Nomura T (1993) Megakaryocyte, erythroid and granulocyte macrophage colony formation in myelodysplastic syndromes.Acta Hematologica89, 113–118
Dexter TM, Allen TD & Lajtha L (1977) Conditions controlling the proliferation of
hemopoietic stem cell in vitro.Journal of Cellular Physiology91, 335–344
Dick JE (1996) Normal and leukemic human stem cells assayed in SCID mice.Seminars in
Immunology 8, 197–206
Ferrajoli A, Talpaz M, Kurzrock R, Harris D, Van Q, Estey EH & Estrov E (1998) Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation.Leukemia & Lymphoma30, 279–292
Flores E, Montesinos JJ, Gutierrez G & Mayani H (2000) Functional characterization of bone marrow fibroblasts and macrophages from patients with myelodysplastic síndromes.Experimental Hematology28 (supplement 1), 95 (abstract)
Flores-Figueroa E, Gutierrez-Espindola G, Guerrero-Rivera S, Pizzuto-Chavez J & Mayani H (1999) Hematopoietic progenitor cells from patients with myelodysplastic syndromes: In vitro colony growth and long-term proliferation.Leukemia Research23, 385–394
Fontenay-Roupie M, Bouscary D, Guesnu M, Picard F, Melle J, Lacon, Gisselbrecht S, Mayeux P & Dreyfus F (1999) Ineffective erythropoiesis in the myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction.British Journal of Haematology106, 464–473
Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M & Bhatia M (2000) Isolation and characterization of human CD34-Lin and CD34’ Lin hematopoietic stem cells using surface markers AC133 and CD7.Blood95, 2813–2820
Glinsmann-Gibson B, Spier C, Baier M, Taetle R, Broudy VC & List AF (1994) Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.Leukemia8, 827–832
Greenberg PL (1996) Biologic and clinical implications of marrow culture studies in the myelodysplastie syndromes.Seminars in Hematology33, 163–175
Greenberg PL & Mara B (1979) The preleukemic syndrome. Correlation of in vitro parameters of granulopoiesis with clinical features.The American Journal of Medicine66, 951–958
Heaney ML & Golde DW (1999) Myelodysplasia.New England Journal of Medicine340, 1649–1660
Hirayama Y, Kohgo Y, Matsunaga T, Ohi S, Sakamaki S & Niitsu Y (1993) Cytokine mRNA expression of bone marrow stromal cells from patients with aplastic anemia and myelodysplastic syndrome.British Journal of Haematology85, 676–683
Hoefsloot LH, van Amelsvoort MP, Broeders LC, van der Plas DC, van Lom K, Hoogerbrugge H, Touw IP & Lowenberg B (1997) Erythropoietin-induced activation of STATS is impaired in the myelodysplastic syndrome.Blood89, 1690–1700
Jacobs A (1985) Myelodysplastic syndromes: pathogenesis, functional abnormalities and clinical implications.Journal of Clinical Pathology38, 1201–1217
Janssen JW, Buschle M&Layton M (1989) Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin.Blood73, 248–254
Juneja H & Gardner FH (1985) Functionally abnormal marrow stromal cells in aplastic anemia.Experimental Hematology13, 194–199
Juvonen E, Aimolahti A, Volin L & Ruutu T (1999) The prognostic value of in vitro cultures of erythroid and megakaryocyte progenitors in myelodysplastic syndromes.Leukemia Research23, 889–894
Kalina U, Hofmann W, Koschmieder S, Wagner S, Kauschat D, Hoelzer D & Ottmann OG (2000) Alterations of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes.Experimental Hematology28, 1158–1163
Kanamura A & Tamura S (1993) Application of long-term bone marrow cultures for studying the leukemic transformation of myelodysplastic syndromes.Leukemia & Lymphoma11, 345–352
Kere J, Ruutu T & de la Chapelle A (1987) Monosomy 7 in granulocytes and monocytes in myelodysplastic syndrome.New England Journal of Medicine316, 499–506
Kitagawa M, Saito I, Kuwata T, Yoshida S, Yamaguchi S, Takahashi M, Tanizawa T, Kamiyama R & Hirokawa K (1997) Overexpression of tumor necrosis factor (TNF)a and interferon (IFN)-y by bone marrow cells from patients with myelodysplastic syndromes.Leukemia 112049–2054
Koike M, Ishiyama T, Tomoyasu S & Tsuruoka N (1995) Spontaneous cytokine overproduction by peripheral blood mononuclear cells from patients with myelodysplastic syndromes and aplastic anemia.Leukemia Research19, 639–644
Kroef MJPL, Fibbe WE & Mout R (1993) Myeloid but not lymphoid cells carry the 5q deletion: polymerase chain reaction analysis of loss of heterozygosity using mini repeat sequences on highly purified cell fractions.Blood81, 1849–1854
Masters GS, Baines P, Tang C, Bowen DT & Burnett AK (1995) Responsiveness to stem cell factor (SCF) of peripheral blood colony forming cells from patients with myelodysplastic syndromes (MDS).Leukemia Research19, 561–566
Mayani H (1993) Human preleukemia: cellular, molecular and clinical aspects.Archives of Medical Research24, 317–324
Mayani H (1996) Composition and function of the hemopoietic microenvironment in human myeloid leukemia.Leukemia10, 1041–1047
Mayani H, Baines P, Bowen DT & Jacobs A (1989) In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor.Leukemia3, 29–32
Mayani H, Guilbert LJ & Janowska-Wieczorek A (1992) Biology of the hemopoietic microenvironment.European Journal of Haematology49, 225–233
Mayani H, Little MT, Dragowska W, Thombury G & Lansdorp PM (1995) Differential effects of the hematopoietic inhibitors MIP-1 a, TGF-fl and TNF-a on cytokine induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.Experimental Hematology23, 422–427
Merchav S, Nielsen OJ, Rosenbaum H, Sharon R, Brenner B, Tatarsky I, Scigalla P & Wieczorek L (1990) In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndrome.Leukemia4, 771–774
Merchav S, Wagemarker G, Souza LM & Tatarsky I (1991) Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haematopoietic growth factors.Leukemia5, 340–346
Metcalf D (1977) Hematopoietic colonies. In vitro cloning of normal and leukemic cells. Springer-Verlag, Berlin-Heidelberg, p.227.
Metcalf D (1993) Hematopoietic regulators: redundancy or subtlety?Blood82, 3515–3523
Michaux JL & Martiat P (1993) Chronic myelomonocytic leukemia (CMML)- a myelodysplastic or myeloproliferative syndrome?.Leukemia & Lymphoma9, 35–41
Montesinos JJ, Flores P, Flores E, Martínez G & Mayani H (2000) In vitro proliferation and expansion of human hematopoietic progenitor cells from normal subjects and patients with hematologic neoplasias.Experimental Hematology28 (supplement 1), 95 (abstract)
Moore MAS (1991) Clinical implications of positive and negative hematopoietic stem cell regulators.Blood78, 1–19
Murphy MJ (1994) Polyfunctionality of hemopoietic regulators. The Metcalf Forum. AlphaMed Press, Dayton, USA p.326
Nilsson L, Astrand-Grundstrom I, Arvidsson I, Jacobsson B, Hellstrom-Lindberg E, Hast R & Jacobson SEW (2000) Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood 96, 2012–2021
Ohmori S, Ohmori M, Yamagishi M & Okuma M (1993) MDS-macrophage derived inhibitory activity on myelopoiesis of MDS abnormal clones. British Journal of Haematology 83, 388–391
Piacibello W, Sanavio F, Bresso P, Severino A, Carlesso N, Pregno P, Stacchini A, Morelli S, Fubini L, Gallo E, Aglietta M & Ferrero D (1994) Stem cell factor improvement of proliferation and maintenance of hematopoietic progenitors in myelodysplastic syndromes.Leukemia8, 250–257
Raza A, Gregory SA & Preisler HD (1996) the myelodysplastic syndromes in 1996: Complex stem cell disorders confounded by dual actions of cytokines.Leukemia Research20, 881–890
Saitoh K, Miura I, Takahashi N & Miura AB (1998) Fluorescence in situ hybridization of progenitor cells obtained by fluorescence activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes.Blood92, 2886–2892
Sato T, Kim S, Selleri C, Young NS & Maciejewski JP (1998) Measurement of secondary colony formation after 5 weeks in long-terni cultures in patients with myelodysplastic syndrome.Leukemia12, 1187–1194
Sawada K (1996) Proliferation and differentiation of myelodysplastic CD34+ cells.Leukemia & Lymphoma12, 43–51
Sawada K, Sato N, Tarumi T, Sakai N, Koizumi K, Sakurama S, leko M, Yasukouchi T, Koyanagawa Y, Yamaguchi M, Ohmoto A, Kohno M & Koike T (1993) Proliferation and differentiation of myelodysplastic CD34+ cells in serum-free medium: response to individual colony-stimulating factors.British Journal of Haematology83, 349–358
Sawada K, Sato N, Notoya A, Tarumi T, Hirayama S, Takano H, Koizumi K, Yasukouchi T, Yamaguchi M & Koike T (1995) Proliferation and differentiation of myelodysplastic CD34+ cells: Phenotypic subpopulations of marrow CD34+ cells.Blood85, 194–202
Schipperus M, Sonneveld P, Lindemans J, Hagemeijer A, Vink N, Pegels J & Abels J (1990) The effects of interleukin-3, GM-CSF and G CSF on the growth kinetics of colony forming cells in myelodysplastic syndromes.Leukemia 4267–272
Shetty V, Mundle S, Alvi S, Showel M, Broady-Robinson L, Dar S, Borok R, Showel J, Gregory S, Rifkin S, Gezer S, Parcharidou A, Venugopal P, Shah R, Hernandez B, Klein M, Alson D, Robin E, Dominguez C & Raza A (1996) Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.Leukemia Research20, 891–899
Shih LY, Chiu WF & Lee CT (1991) Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte macrophage progenitors in patients with myelodysplastic syndrome.Leukemia5, 1092–1098
Soligo D, Servida F, Cortelezzi A, Pedretti D, Uziel L, Morgutti M, Pogliani E & Lambertenghi Deliliers G (1994) Effects of recombinant human stem cell factor (rh SCF) on colony formation and long-term bone marrow cultures (LTBMC) in patients with myelodysplastic síndromes.European Journal of Haematology52, 53–60
Soligo DA, Campiglio S, Servida F, Bossolasco P, Romitti L, Cortelezzi & Lambertenghi Deliliers G (1996) Response of myelodysplastic syndrome marrow progenitor cells stimulation with cytokine combination in a stroma-free long-term culture system.British Journal of Haematology92, 548–558
Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM (1989) Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro.Blood74, 1563–1570
Szilvassy SJ & Hoffman R (1995) Enriched hematopoietic stem cells: Basic biology and clinical utility.Biology of Blood and Marrow Transplantation1, 3–17
Tohyama K, Ueda T, Yoshida Y & Nakamura T (1994) Altered responses of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors in vitro: comparison with normal blast cells.Experimental Hematology22, 539–545
Thomas TE, Miller CL & Eaves CJ (1999) Purification of hematopoietic stem cells for further biological study.Methods. A companion to Methods in Enzymology17, 202–218
Visani G, Zauli G, Tosi P, Fogli M, Cenaucchi A, Finelli C, Gamberi B, Ottaviani E, Manfoi S & Tura S (1993) Impairment of GM-CSF production in myelodysplastic syndromes.British Journal of Haematology84, 227–231
Wetzler M, Kurzrock R, Estrov Z, Estey E & Talpaz M (1995) Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia.Leukemia Research19, 23–34
Yoshida Y (1987) Biology of myelodysplastic syndromes.International Journal of Cell Cloning5, 356–375
Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW & Ogawa M (1998) Human bone marrow CD34-negative cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34-positive cells.Experimental Hematology26, 353-360
Ziegler BL, Valtieri M, Almeida Porada G, De Maria R, Müller R, Masella B, Gabianelli M, Casella I, Pelosi E, Bock T, Zanjani ED & Peschle C (1999) KDR receptor: A key marker defining hematopoietic stem cells.Science285, 1553–1558
Zwierzina H, Schollenberger S, Herold M, Schmalzl F & Besemer J (1992) Endogenous serum levels and surface receptor expression of GM-CSF and IL-3 in patients with myelodysplastic syndromes. Leukemia Research 16, 1181–1186
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mayani, H. (2001). In Vitro Biology of the Hematopoietic System in Myelodysplastic Syndromes. In: Raza, A., Mundle, S.D. (eds) Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia. Cancer Treatment and Research, vol 108. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1463-3_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1463-3_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5566-3
Online ISBN: 978-1-4615-1463-3
eBook Packages: Springer Book Archive